Rivastigmine as a Symptomatic Treatment for Apathy in Parkinson's Dementia Complex: New Aspects for This Riddle
Sign Up to like & getrecommendations! Published in 2017 at "Parkinson's Disease"
DOI: 10.1155/2017/6219851
Abstract: Over 90% of PDD patients show at least one neuropsychiatric symptom (NPS); in the 60–70% two or more NPS are present. Their incidence is important in terms of prognosis and severity of pathology. However, among… read more here.
Keywords: rivastigmine; treatment apathy; symptomatic treatment; parkinson dementia ... See more keywords